慢性乙型肝炎患者血清HBV DNA、HBeAg与肝组织HBcAg及炎症分级的关系

刘兴祥; 李桂珍; 徐云芳; 张菁

doi:10.3969/j.issn.1001-5256.2013.12.011

慢性乙型肝炎患者血清HBV DNA、HBeAg与肝组织HBcAg及炎症分级的关系

DOI: 10.3969/j.issn.1001-5256.2013.12.011

淮安市第四人民医院肝病研究所

基金项目:

淮安市科技基金资助(HAS2012025)；

详细信息

中图分类号: R512.62
计量
- 文章访问数: 2809
- HTML全文浏览量: 16
- PDF下载量: 591
- 被引次数: 0
出版历程
- 收稿日期: 2013-05-03
- 出版日期: 2013-12-20

Relationship between HBV DNA and HBeAg in serum and HBcAg and inflammation grade in liver tissue among patients with chronic hepatitis B

Institute of Liver Disease, The Fourth People' s Hospital of Huai'an

Research funding:

摘要

摘要: 目的探讨慢性乙型肝炎(CHB)患者血清HBV DNA、HBeAg与肝组织HBcAg及炎症分级的关系。方法回顾性分析250例CHB肝穿刺患者,按血清HBV DNA水平,分为A组(<3 log10IU/ml)45例,B组(3~6 log10IU/ml)138例,C组(>6 log10IU/ml)67例。按HBeAg阴阳性不同分为阳性组142例,阴性组108例。分别与肝组织中HBcAg水平、肝组织炎症分级进行比较,分析彼此的相关性,率的比较用卡方检验及确切概率法,相关性分析采用直线相关分析。结果血清HBV DNA不同水平与肝组织HBcAg免疫组化比较差异有统计学意义(χ2=11.1,P=0.05),两者之间呈正相关(r=0.75,P=0.001);与肝组织炎症分级(G)比较差异无统计学意义(χ2=13.3,P=0.075),两者之间也无相关性(r=0.04,P=0.325)。HBeAg阳性和阴性分组与肝组织中HBcAg水平比较差异有统计学意义(χ2=6.64,P=0.01),两者之间呈正相关(r=0.56,P=0.001);与肝组织炎症分级(G)比较差异无统计学意义(χ2=8.4...
- 肝炎,乙型,慢性 /
- 肝炎e抗原,乙型 /
- 肝炎核心抗原,乙型 /
- 肝炎病毒,乙型
Abstract: Objective To investigate the relationship between HBV DNA and HBeAg in serum and HBcAg and inflammation grade in liver tissue among chronic hepatitis B ( CHB) patients. Methods A retrospective analysis was performed on 250 CHB patients who underwent liver biopsy. These patients were divided into three groups according to serum levels of HBV DNA: group A ( < 3 log10IU / ml, n = 45) , group B ( 3-6 log10IU / ml, n = 138) , and group C ( > 6 log10IU / ml, n = 67) , and they were also divided into HBeAg-positive group ( n= 142) and HBeAg-negative group ( n = 108) . The positive rate of HBcAg and inflammation grade in liver tissue were compared between groups, and correlations were analyzed. Comparisons of rates were made by chi-square test and Fisher's exact test; correlations were determined by linear correlation analysis. Results There were significant differences in positive rate of HBcAg between groups A, B, and C ( χ2= 11. 1, P = 0. 05) , and serum HBV DNA level was positively correlated with the positive rate of HBcAg in liver tissue ( r = 0. 75, P =0. 001) . There were no significant differences in inflammation grade between groups A, B, and C ( χ2= 13. 3, P = 0. 075) , and no correlation was found between serum HBV DNA level and inflammation grade in liver tissue ( r = 0. 04, P = 0. 325) . There was significant difference in positive rate of HBcAg between the HBeAg-positive group and HBeAg-negative group ( χ2= 6. 64, P = 0. 01) , and the presence or absence of HBeAg in serum was positively correlated with the positive rate of HBcAg in liver tissue ( r = 0. 56, P = 0. 001) . There was no significant difference in inflammation grade between the HBeAg-positive group and HBeAg-negative group ( χ2= 8. 43, P = 0. 065) , and no correlation was found between the presence or absence of HBeAg in serum and inflammation grade in liver tissue ( r = 0. 06, P = 0. 415) .Conclusion The expression of HBcAg in liver tissue can better reflect HBV replication in the liver among CHB patients. When HBV markers cannot be detected in the serum of patients, liver biopsy can be used to detect HBcAg in liver tissue and assess HBV replication.
- hepatitis B, chronic /
- hepatitis B e antigens /
- hepatitis B core antigens /
- hepatitis B virus

HTML全文

参考文献(10)

[1]Committee of Experts on Antiviral Therapy of Chronic Hepatitis B.Experts consensus on antiviral therapy of chronic hepatitis B[J].J Clin Hepatol, 2010, 26 (2) :125-130. (in Chinese) 慢性乙型肝炎抗病毒治疗专家委员会.慢性乙型肝炎抗病毒治疗专家共识[J].临床肝胆病杂志, 2010, 26 (2) :125-130.

[2]Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline for prevention and treatment of chronic hepatitis B[J].J Clin Hepatol, 2006, 22 (1) :3-15. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南[J].临床肝胆病杂志, 2006, 22 (1) :3-15.

[3]MOMMEJA-MARIN H, MONDOU E, BLUM MR, et al.Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection:analysis and review of the literature[J].Hepatology, 2003, 37 (6) :1309-1319.

[4]GAO M, LU CZ, WANG Y, et al, Relationship between expression of HBcAg in liver tissue and characteristics of the hepatic pathological features in patients with chronic hepatitis B virus infection[J].J Clin Hepatol, 2012, 28 (3) :201-204. (in Chinese) 高敏, 卢诚震, 王怡, 等.慢性乙型肝炎病毒感染者肝组织HBcAg表达与临床及病理特征的关系[J].临床肝胆病杂志, 2012, 28 (3) :201-204.

[5]PAN HY, ZHANG YL, CHEN CR, et al, Clinical significance of intrahepatic hepatitis B core antigen (+) in patients with chronic hepatitis B[J].Chin J Hepatol, 2007, 15 (8) :582-584. (in Chinese) 潘红英, 张永乐, 谌翠容, 等.慢性乙型肝炎患者肝细胞内乙型肝炎核心抗原阳性的临床意义[J].中华肝脏病杂志, 2007, 15 (8) :582-584.

[6]European Associantion for the Study of the Liver.EASL clinical practice guidelines:Management of chronic hepatitis B[J].Gastroenterol Clin Biol, 2009, 33 (6-7) :539-554.

[7]HOOFNAGLE JH, DOO E, LIANG TJ, et al.Management of hepatitis B;summary of a clinical research workshop[J].Hepatology, 2007, 45 (4) :1056-1075.

[8]LOK AS, Mc MARHON BJ.Chronic hepatitis B[J].Hepatology, 2007, 45 (2) :507-539.

[9] LU CT, ZHOU WH, HU AR.Study on the relationship between HBV viral loads and the changes of liver pathological features in patients with HBeAg-negative chronic hepatitis B[J].Chinese J Exp Clin Virol, 2010, 24 (3) :184-186. (in Chinese) 陆传统, 周文红, 胡爱荣, HBeAg阴性慢性乙型肝炎患者血清病毒载量与肝组织学改变的关系[J].中华实验和临床病毒学杂志, 2010, 24 (3) :184-186.

[10]ZHUANG L, YOU J, LEI H, et al.Study of liver pathology in mild ALT-elevated chronic hepatitis B patients with different HBV DNA levels[J].J Clin Hepatol, 2011, 27 (12) :1278-1281. (in Chinese) 庄林, 游晶, 雷华, 等, ALT轻度升高、HBV DNA水平不同的慢性乙型肝炎患者肝组织学差异探讨[J].临床肝胆病杂志, 2011, 27 (12) :1278-1281.

施引文献

资源附件(0)

访问统计